NCT03309956

Brief Summary

This prospective study aims to compare the diagnostic yield, or ability to detect an arrhythmia, of the traditional Holter monitor versus the novel Zio patch monitor in pediatric patients referred for ambulatory electrocardiographic (ECG) monitoring. Children will wear both devices simultaneously for 48 hours and the incidence of clinically significant arrhythmias will be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
247

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 16, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

October 18, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 19, 2019

Completed
4.7 years until next milestone

Results Posted

Study results publicly available

June 18, 2024

Completed
Last Updated

June 18, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

October 5, 2017

Results QC Date

September 20, 2021

Last Update Submit

May 22, 2024

Conditions

Keywords

Ambulatory ElectrocardiographyHolter MonitorZio Patch MonitorPediatrics

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Difference in Detection of Clinically Significant Arrhythmias for the Zio Versus the Holter

    The diagnostic yield, or the ability to detect an arrhythmia, will be measured for the Holter monitor and the Zio patch monitor for each patient. The diagnostic yield for each arrhythmia subtype will be determined for each device across all patients and compared in paired statistical analysis (McNemar's test).

    48 hours

Secondary Outcomes (1)

  • Prevalence of Artifact Detected

    48 hours

Other Outcomes (1)

  • Percentage of Patients Who Preferred the Zio Over the Holter

    48 hours

Study Arms (1)

Holter Monitor and Zio Patch

OTHER

All subjects will wear the Holter monitor and Zio patch for a total of 48 hours.

Device: Holter MonitorDevice: Zio Patch

Interventions

A Holter monitor is a battery-operated portable device that measures and records your heart's electrical activity (ECG) continuously. Patients in this study will wear the monitor for 48 hours.

Holter Monitor and Zio Patch
Zio PatchDEVICE

The Zio Patch is a small, adhesive, water-resistant single lead electrocardiographic monitoring device. Patients in this study will wear the patch for 48 hours.

Holter Monitor and Zio Patch

Eligibility Criteria

AgeUp to 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Any patient under age 22 years who has been referred for ambulatory ECG monitoring at Children's Hospital of New York.

You may not qualify if:

  • Any known skin allergy or sensitivity to adhesive material.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Medical Center

New York, New York, 10032, United States

Location

Related Publications (8)

  • Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, Fought AJ, Topol EJ. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014 Jan;127(1):95.e11-7. doi: 10.1016/j.amjmed.2013.10.003. Epub 2013 Oct 15.

    PMID: 24384108BACKGROUND
  • Bolourchi M, Batra AS. Diagnostic yield of patch ambulatory electrocardiogram monitoring in children (from a national registry). Am J Cardiol. 2015 Mar 1;115(5):630-4. doi: 10.1016/j.amjcard.2014.12.014. Epub 2014 Dec 18.

    PMID: 25591894BACKGROUND
  • Cheung CC, Kerr CR, Krahn AD. Comparing 14-day adhesive patch with 24-h Holter monitoring. Future Cardiol. 2014 May;10(3):319-22. doi: 10.2217/fca.14.24.

    PMID: 24976467BACKGROUND
  • Lobodzinski SS. ECG patch monitors for assessment of cardiac rhythm abnormalities. Prog Cardiovasc Dis. 2013 Sep-Oct;56(2):224-9. doi: 10.1016/j.pcad.2013.08.006.

    PMID: 24215754BACKGROUND
  • Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33. doi: 10.1111/pace.12053. Epub 2012 Dec 13.

    PMID: 23240827BACKGROUND
  • Schreiber D, Sattar A, Drigalla D, Higgins S. Ambulatory cardiac monitoring for discharged emergency department patients with possible cardiac arrhythmias. West J Emerg Med. 2014 Mar;15(2):194-8. doi: 10.5811/westjem.2013.11.18973.

    PMID: 24672611BACKGROUND
  • Tung CE, Su D, Turakhia MP, Lansberg MG. Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA. Front Neurol. 2015 Jan 12;5:266. doi: 10.3389/fneur.2014.00266. eCollection 2014.

    PMID: 25628595BACKGROUND
  • Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, Xu X, Yang F, Heidenreich PA. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013 Aug 15;112(4):520-4. doi: 10.1016/j.amjcard.2013.04.017. Epub 2013 May 11.

    PMID: 23672988BACKGROUND

MeSH Terms

Conditions

Arrhythmias, CardiacHeart Block

Interventions

Electrocardiography, Ambulatory

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCardiac Conduction System Disease

Intervention Hierarchy (Ancestors)

ElectrocardiographyHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMonitoring, AmbulatoryMonitoring, Physiologic

Results Point of Contact

Title
Leonardo Liberman, MD
Organization
Columbia University

Study Officials

  • Leonardo Liberman, MD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All patients will receive the same intervention, namely both devices at the same time for 48 hours.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2017

First Posted

October 16, 2017

Study Start

October 18, 2017

Primary Completion

October 19, 2019

Study Completion

October 19, 2019

Last Updated

June 18, 2024

Results First Posted

June 18, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations